Anti-mTOR (phospho S2448)抗体(ab1093)

Submit a review Q&A (1)References (11)

概述

  • 产品名称
    Anti-mTOR (phospho S2448)抗体
    参阅全部 mTOR 一抗
  • 描述
    兔多克隆抗体to mTOR (phospho S2448)
  • 宿主
    Rabbit
  • 经测试应用
    适用于: IHC-P, WB, ELISAmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Synthetic peptide: KRSRTRTDpSYSAGQSVEI, corresponding to C terminal amino acids 2440-2463 of Human mTOR.

    Run BLAST with BLAST the sequence with ExPASy Run BLAST with BLAST the sequence with NCBI
  • 阳性对照
    • serum starved 293T cell lysate

性能

应用

Our Abpromise guarantee covers the use of ab1093 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IHC-P Use a concentration of 5 µg/ml.
WB 1/1000. Detects a band of approximately 250 kDa (predicted molecular weight: 288 kDa).
ELISA 1/6000 - 1/29000. Assayed aginst 0.1 µg of the immunizing peptide and has not been tested against the endogenous protein.

靶标

  • 功能
    Kinase subunit of both mTORC1 and mTORC2, which regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino-acids. Growth factor-stimulated mTORC1 activation involves AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Amino-acid-signaling to mTORC1 requires its relocalization to the lysosomes mediated by the Ragulator complex and the Rag GTPases. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-421', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. Phosphorylates MAF1 leading to attenuation of its RNA polymerase III-repressive function. mTORC2 is also activated by growth. factors, but seems to be nutrient-insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'.
  • 组织特异性
    Expressed in numerous tissues, with highest levels in testis.
  • 序列相似性
    Belongs to the PI3/PI4-kinase family.
    Contains 1 FAT domain.
    Contains 1 FATC domain.
    Contains 7 HEAT repeats.
    Contains 1 PI3K/PI4K domain.
  • 翻译后修饰
    Autophosphorylated; when part of mTORC1 or mTORC2.
  • 细胞定位
    Endoplasmic reticulum membrane. Golgi apparatus membrane. Mitochondrion outer membrane. Lysosome. Cytoplasm. Nucleus > PML body. Shuttles between cytoplasm and nucleus. Accumulates in the nucleus in response to hypoxia (By similarity). Targeting to lysosomes depends on amino acid availability and RRAGA and RRAGB.
  • Information by UniProt
  • 数据库链接
    • 别名
      • dJ576K7.1 (FK506 binding protein 12 rapamycin associated protein 1) antibody
      • FK506 binding protein 12 rapamycin associated protein 1 antibody
      • FK506 binding protein 12 rapamycin associated protein 2 antibody
      • FK506 binding protein 12 rapamycin complex associated protein 1 antibody
      • FK506-binding protein 12-rapamycin complex-associated protein 1 antibody
      • FKBP rapamycin associated protein antibody
      • FKBP12 rapamycin complex associated protein antibody
      • FKBP12-rapamycin complex-associated protein 1 antibody
      • FKBP12-rapamycin complex-associated protein antibody
      • FLJ44809 antibody
      • FRAP antibody
      • FRAP1 antibody
      • FRAP2 antibody
      • Mammalian target of rapamycin antibody
      • Mechanistic target of rapamycin antibody
      • mTOR antibody
      • MTOR_HUMAN antibody
      • OTTHUMP00000001983 antibody
      • RAFT1 antibody
      • Rapamycin and FKBP12 target 1 antibody
      • Rapamycin associated protein FRAP2 antibody
      • Rapamycin target protein 1 antibody
      • Rapamycin target protein antibody
      • RAPT1 antibody
      • Serine/threonine-protein kinase mTOR antibody
      see all

    图片

    • Western blot - Anti-mTOR (phospho S2448) antibody (ab1093)
      Western blot - Anti-mTOR (phospho S2448) antibody (ab1093)This image is courtesy of Angela Carter, Experimental Therapeutics, Ontario Cancer Inst, Toronto, Canada

      Rabbit polyclonal to phospho mTOR (Ser 2448) at 1/1000 on 293T cell extract shows a band at approx 250 kDa.
      Cells were serum starved for 24 hours:

      Lane 1 : control
      Lane 2 : treated with IGF-1 (100 ng/ml) for 20 min

      Rabbit polyclonal to phospho mTOR (Ser 2448) at 1/1000 on 293T cell extract shows a band at approx 250 kDa. Cells were serum starved for 24 hours:
      Lane 1 : control
      Lane 2 : treated with IGF-1 (100 ng/ml) for 20 min

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-mTOR (phospho S2448) antibody (ab1093)
      Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-mTOR (phospho S2448) antibody (ab1093)

      ab1093 at 5 µg/ml staining proximal convulted tubules of the kidney.  The image shows localization of the antibody as the precipitated red signal, with a hematoxylin purple nuclear counterstain.

    文献

    This product has been referenced in:
    • Thongon N  et al. Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA. Cancer Metab 6:1 (2018). Read more (PubMed: 29541451) »
    • Vitellius C  et al. The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma. Oncotarget 9:28069-28082 (2018). Read more (PubMed: 29963262) »
    See all 11 Publications for this product

    发表研究结果有使用 ab1093？请让我们知道，以便我们可以引用本数据表中的参考文章。

    客户评价及客户问答

    Show All 评价 Q&A
    提交评价 提交问题

    Question

    BATCH NUMBER 125112 ORDER NUMBER 94471 DESCRIPTION OF THE PROBLEM No signal at all SAMPLE WCL isolated from cultured HepG2 , HCT116, DLD1, SUV480 and HT29 cells PRIMARY ANTIBODY Dilution: 1:1000 Dilution buffer: TBS-Tween 20(0.1%) with 5% BSA incubation: overnight at 4 degrees Waching step: wash with TBS-Tween 20(0.1%) , 5min x 3 DETECTION METHOD ECL plus system POSITIVE AND NEGATIVE CONTROLS USED No, the customer didn't use both positive and negative controls. ANTIBODY STORAGE CONDITIONS It was stored at -20 degrees. SAMPLE PREPARATION Lysis buffer: CelLytic-M from SIGMA (cat# C2978) Protease inhibitors: protease inhibitor coacktai tablets from Roche (cat# 11697 498001) Loading buffer: TrisGlycine-SDS sample buffer (2x) from Invitrogen Heating sample: for 5 minutes at 95 degrees AMOUNT OF PROTEIN LOADED approximately 20ug each ELECTROPHORESIS/GEL CONDITIONS 4-12% Tris-Glycine Gel (1.0mm thick) from Invitrogen TRANSFER AND BLOCKING CONDITIONS Blocking buffer: TBS-Tween 20 (0.1%) Blocking agent: 5% non-fat dry milk incubation : for 1 hour at room temp SECONDARY ANTIBODY 2nd Ab: Anti rabbit IgG-HRP conjugated Dilution: 1:10000 Incubation: for 1 hour at room temp Wash step: TBS-Tween 20(0.1%), 5min x 3 HOW MANY TIMES HAVE YOU TRIED THE APPLICATION? 1 ADDITIONAL NOTES Would you please let me know how we should advise her about this matter?

    Read More
    Answer

    I'm sorry to hear one of your customers is experiencing a problem with ab1093. We have not tested this antibody in cultured HepG2 , HCT116, DLD1, SUV480 and HT29 cells and I think the customer's problem is due to the fact that these cells contain low levels of the phosphorylated protein, undetectable by WB with ab1093. For example, a paper by Paajarvi et al (FASEB J. 2005 Mar;19(3):476-8. Epub 2004 Dec 29.) shows that HepG2 cells (even serum starved) have very low levels of basal phosphoS448 mTOR and need to be stimulated with pravastin 2uM and insulin 1ugl/ml (1hr) to have a significant level of the phosphorylated protein. Therefore I strongly suggest that the customer runs the recommended positive control of serum starved 293T cell lysate (preferably nuclear lysate) and to also do a nuclear extraction step to concentrate the protein in her samples. Please ask her to try a 1:500 dilution of the antibody and make sure the secondary antibody is not damaged. I also noticed the customer blocked with two blocking agents (BSA and milk), this can cause problems too so ask her to do a 1hr 5%BSA block and use only TBST to dilute the primary and secondary antibodies (milk contains casein which is a phospho protein so causes interference with phospho-specific antibodies). Please let me know if you need any further assistance,

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    注册